Previous studies have demonstrated the upregulation of Fyn in the AD brain (Shirazi and Wood, 1993) and the presence of a Fyn phosphorylation site in Tau(Lee et al., 2004), which further supports a role for Fyn in the pathogenesis of neurodegenerative disorders. The gene discussed is MAPT; the disease is Alzheimer disease.